Cadmium Sulphide (CdS) Nanotechnology: Synthesis and Applications

2008 ◽  
Vol 8 (7) ◽  
pp. 3272-3299 ◽  
Author(s):  
N. V. Hullavarad ◽  
S. S. Hullavarad ◽  
P. C. Karulkar

Over the past few years there has been sustained interest in the synthesis, characterization and application of cadmium sulphide (CdS) nanostructures such as nanoparticles, nanowires, nanobelts, nanospheres. The history of CdS, more recent advances in the chemistry and synthesis of CdS nanostructures, and their application as nanoscale devices in diverse technology areas from electronics to targeted drug delivery is described. Although the focus is on CdS, the review provides an excellent overview of the materials, methods, processes and promising solutions that are emerging.

2009 ◽  
Vol 17 (9) ◽  
pp. 671-689 ◽  
Author(s):  
Adnan Azeem ◽  
Md. Khalid Anwer ◽  
Sushama Talegaonkar

2015 ◽  
Vol 3 (7) ◽  
pp. 1025-1034 ◽  
Author(s):  
Jason Bugno ◽  
Hao-jui Hsu ◽  
Seungpyo Hong

Synthesis of dendrimers and their modified nanoparticles.


Author(s):  
Hai Yang Shu ◽  
Ren De Zhu ◽  
Jing Wu ◽  
Xin Hua Liu ◽  
Jing Bo Shi

: Uncaging chemistry catalyzed by transition metals is developed from deprotection reactions and metal-organic catalytic reactions. Also, it has the characteristics of high efficiency, simplicity, and rapidity in the living biological system. In the past decade, metal encapsulation systems (such as nanoparticles) and metal complexes have been developed to reveal the reactivity of transition metals (including palladium, ruthenium, and gold) in biological systems. Metal nanostructures provide huge possibilities for targeted drug delivery, detection, diagnosis, and imaging. So far, palladium, ruthenium and gold nano-architectures have dominated in the field, but there are some problems that hinder its wide application in clinical practice. In this review, based on palladium, ruthenium, gold, and their complexes, the application of prodrug design through uncaging reaction was widely discussed.


2015 ◽  
Vol 16 (6) ◽  
pp. 542-548 ◽  
Author(s):  
Xibo Ma ◽  
Hui Hui ◽  
Wenting Shang ◽  
Xiaohua Jia ◽  
Xin Yang ◽  
...  

2017 ◽  
Vol 110-111 ◽  
pp. 169-187 ◽  
Author(s):  
Sharareh Eskandari ◽  
Thalia Guerin ◽  
Istvan Toth ◽  
Rachel J. Stephenson

Nanomedicine ◽  
2020 ◽  
Vol 15 (19) ◽  
pp. 1861-1871
Author(s):  
Lorenzo Taiarol ◽  
Beatrice Formicola ◽  
Roberta Dal Magro ◽  
Silvia Sesana ◽  
Francesca Re

Glioblastoma multiforme is a serious medical issue in the brain oncology field due to its aggressiveness and recurrence. Immunotherapy has emerged as a valid approach to counteract the growth and metastasization of glioblastoma multiforme. Among the different innovative approaches investigated, nanoparticles gain attention because of their versatility which is key in allowing precise targeting of brain tumors and increasing targeted drug delivery to the brain, thus minimizing adverse effects. This article reviews the progress made in this field over the past 2 years, focusing on nonspherical and biomimetic particles and on vectors for the delivery of nucleic acids. However, challenges still need to be addressed, considering the improvement of the particles passage across the blood–meningeal barrier and/or the blood–brain barrier, promoting the clinical translatability of these approaches.


Sign in / Sign up

Export Citation Format

Share Document